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Pathway
• Risk: Exposures to CO2 during                        
spaceflight
• Risk Management: Spacecraft                         
Maximum Allowable Concentrations
(SMACs)
• Reality: Current ISS status with CO2
• Revision: Attempts to associate elevated CO2 with 
acute adverse effects
• Revision: Attempts to associate sustained and 
elevated CO2 levels with adverse effects
• Selectivity: Thoughts on genetic differences
• Transition to Operations: flight rules
Risk: 24-hr exposures to CO2 during 
spaceflight from MCA Data
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Risk Management: Spacecraft Maximum Allowable 
Concentrations (SMACs)
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CO2 Control aboard the ISS
Reality: Current ISS status with CO2: 6 
crewmembers and Vozdukh operating
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Revision: Attempts to associate elevated CO2
levels with acute adverse effects
• Behavioral Effects-WinSCAT
– Mathematical  Processing
– Continuous Performance Task
– Code Substitution Delayed Recognition
– Match to Sample
– Looked at total score, sub-scores, and changes in these
– Compared to CO2 averages and peak levels 1 and 7 days before
• Headaches
– 12 Identified from private 
medical conferences in ~10 years of operation of ISS
– Searching call down records
• Visual disturbances
Revision: Attempts to associate elevated 
CO2 with lasting adverse effects
– Visual changes are common during prolonged 
missions
– Lasting Visual changes have been reported in a 
few crewmembers after flight
Data Sorting: Headaches vs. Incidence 
in CO2 Bands
• Raw incidence in four bands (% of PMCs)
– <2 mmHg
– 2-3 mmHg
– 3-4 mmHg
– >4 mmHg
• Use arcsine of square root of the decimal % to 
apply benchmark dose analysis
• Calculated average CO2 level in each band
• Tried 5 benchmark dose models (3 ‘worked’)
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Selectivity: Semi-random thoughts on 
genetic differences
• Pigs appear to have widely variable response 
to stunning doses of CO2
• Humans with panic disorder (PD) respond 
differently to high levels of CO2 based on 
subtype
– Respiratory vs. non-respiratory  PD patients
– PD runs in families
– Do high CO2 levels (>5%) have any relevance to 
possible genetic differences in the general 
population?
Transition to Operations: flight rules
• Current flight rule requires more drastic action 
as CO2 levels rise
• In practical terms we try to operate with CO2
below 4 mmHg
• Management also depends on any symptoms 
presumed to be associated with CO2 exposure
• Hardware failures, local pockets, and large 
crew size can pose a challenge to manage CO2
to 3 mmHg or less
Observations & Recommendations
• Aboard ISS we may be faced with some hard choices 
between management of crew health risks and 
practical CO2 management
• Explore differences in response to CO2 levels in the 
range from 2-8 mmHg using ground-based model 
(bedrest?)  identify genetic differences
• Perform blind challenges aboard the ISS to determine 
changes in susceptibility on orbit in the range from 2-8 
mmHg. Use highly sensitive tests to identify significant 
effects.
• We must have a clear grip on CO2
issues before we launch human 
exploration missions.
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